Kari Stefansson

Kari Stefansson

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Kari Stefansson

DeCODE genetics/AMGEN Inc., Reykjavik, Iceland

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2010 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ESElizabeth K Speliotes
Elizabeth K Speliotes
MAMagic
Magic
CWCristen J Willer
Cristen J Willer
SBSonja I Berndt
Sonja I Berndt
KMKeri L Monda
Keri L Monda
OCon behalf of Procardis Consortium
on behalf of Procardis Consortium
Ruth Loos and colleagues report results of a large genome-wide association study for body mass index. They identify 18 new loci associated with this trait, some of which map near key hypothalamic regulators of energy balance. Obesity is globally prevalent and highly heritable, but its underlying genetic factors remain largely elusive. To identify genetic loci for obesity susceptibility, we examined associations between body mass index and ∼2.8 million SNPs in up to 123,865 individuals with targeted follow up of 42 SNPs in up to 125,931 additional individuals. We confirmed 14 known obesity susceptibility loci and identified 18 new loci associated with body mass index (P < 5 × 10−8), one of which includes a copy number variant near GPRC5B. Some loci (at MC4R, POMC, SH2B1 and BDNF) map near key hypothalamic regulators of energy balance, and one of these loci is near GIPR, an incretin receptor. Furthermore, genes in other newly associated loci may provide new insights into human body weight regulation.

25 February 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JGJakob Grove
Jakob Grove
SRStephan Ripke
Stephan Ripke
TAThomas D. Als
Thomas D. Als
MMManuel Mattheisen
Manuel Mattheisen
RWRaymond K. Walters
Raymond K. Walters
BUBupgen
Bupgen
Autism spectrum disorder (ASD) is a highly heritable and heterogeneous group of neurodevelopmental phenotypes diagnosed in more than 1% of children. Common genetic variants contribute substantially to ASD susceptibility, but to date no individual variants have been robustly associated with ASD. With a marked sample-size increase from a unique Danish population resource, we report a genome-wide association meta-analysis of 18,381 individuals with ASD and 27,969 controls that identified five genome-wide-significant loci. Leveraging GWAS results from three phenotypes with significantly overlapping genetic architectures (schizophrenia, major depression, and educational attainment), we identified seven additional loci shared with other traits at equally strict significance levels. Dissecting the polygenic architecture, we found both quantitative and qualitative polygenic heterogeneity across ASD subtypes. These results highlight biological insights, particularly relating to neuronal function and corticogenesis, and establish that GWAS performed at scale will be much more productive in the near term in ASD.

10 January 2013 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
TJThorlakur Jonsson
Thorlakur Jonsson
HSHreinn Stefansson
Hreinn Stefansson
SSStacy Steinberg
Stacy Steinberg
IJIngileif Jonsdottir
Ingileif Jonsdottir
PJPalmi V. Jonsson
Palmi V. Jonsson
KSKari Stefansson
Kari Stefansson
Sequence variants, including the ε4 allele of apolipoprotein E, have been associated with the risk of the common late-onset form of Alzheimer's disease. Few rare variants affecting the risk of late-onset Alzheimer's disease have been found. We obtained the genome sequences of 2261 Icelanders and identified sequence variants that were likely to affect protein function. We imputed these variants into the genomes of patients with Alzheimer's disease and control participants and then tested for an association with Alzheimer's disease. We performed replication tests using case–control series from the United States, Norway, the Netherlands, and Germany. We also tested for a genetic association with cognitive function in a population of unaffected elderly persons. A rare missense mutation (rs75932628-T) in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2), which was predicted to result in an R47H substitution, was found to confer a significant risk of Alzheimer's disease in Iceland (odds ratio, 2.92; 95% confidence interval [CI], 2.09 to 4.09; P=3.42×10−10). The mutation had a frequency of 0.46% in controls 85 years of age or older. We observed the association in additional sample sets (odds ratio, 2.90; 95% CI, 2.16 to 3.91; P=2.1×10−12 in combined discovery and replication samples). We also found that carriers of rs75932628-T between the ages of 80 and 100 years without Alzheimer's disease had poorer cognitive function than noncarriers (P=0.003). Our findings strongly implicate variant TREM2 in the pathogenesis of Alzheimer's disease. Given the reported antiinflammatory role of TREM2 in the brain, the R47H substitution may lead to an increased predisposition to Alzheimer's disease through impaired containment of inflammatory processes. (Funded by the National Institute on Aging and others.)

7 January 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
IJIris E. Jansen
Iris E. Jansen
JSJeanne E. Savage
Jeanne E. Savage
KWKyoko Watanabe
Kyoko Watanabe
JBJulien Bryois
Julien Bryois
DWDylan M. Williams
Dylan M. Williams
DPDanielle Posthuma
Danielle Posthuma

22 August 2012 in Nature
Verified
Journal Article
Open access
PDF file
AKAugustine Kong
Augustine Kong
MFMichael L. Frigge
Michael L. Frigge
GMGisli Masson
Gisli Masson
SBSøren Besenbacher
Søren Besenbacher
PSPatrick Sulem
Patrick Sulem
KSKari Stefansson
Kari Stefansson
Mutations generate sequence diversity and provide a substrate for selection. The rate of de novo mutations is therefore of major importance to evolution. Here we conduct a study of genome-wide mutation rates by sequencing the entire genomes of 78 Icelandic parent–offspring trios at high coverage. We show that in our samples, with an average father’s age of 29.7, the average de novo mutation rate is 1.20 × 10−8 per nucleotide per generation. Most notably, the diversity in mutation rate of single nucleotide polymorphisms is dominated by the age of the father at conception of the child. The effect is an increase of about two mutations per year. An exponential model estimates paternal mutations doubling every 16.5 years. After accounting for random Poisson variation, father’s age is estimated to explain nearly all of the remaining variation in the de novo mutation counts. These observations shed light on the importance of the father’s age on the risk of diseases such as schizophrenia and autism.

26 November 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
DDDitte Demontis
Ditte Demontis
RWRaymond K. Walters
Raymond K. Walters
JMJoanna Martin
Joanna Martin
MMManuel Mattheisen
Manuel Mattheisen
TAThomas D. Als
Thomas D. Als
BNBenjamin M. Neale
Benjamin M. Neale
Attention deficit/hyperactivity disorder (ADHD) is a highly heritable childhood behavioral disorder affecting 5% of children and 2.5% of adults. Common genetic variants contribute substantially to ADHD susceptibility, but no variants have been robustly associated with ADHD. We report a genome-wide association meta-analysis of 20,183 individuals diagnosed with ADHD and 35,191 controls that identifies variants surpassing genome-wide significance in 12 independent loci, finding important new information about the underlying biology of ADHD. Associations are enriched in evolutionarily constrained genomic regions and loss-of-function intolerant genes and around brain-expressed regulatory marks. Analyses of three replication studies: a cohort of individuals diagnosed with ADHD, a self-reported ADHD sample and a meta-analysis of quantitative measures of ADHD symptoms in the population, support these findings while highlighting study-specific differences on genetic overlap with educational attainment. Strong concordance with GWAS of quantitative population measures of ADHD symptoms supports that clinical diagnosis of ADHD is an extreme expression of continuous heritable traits.